Mifepristone Improves A1C in T2D With Hypercortisolism
CHICAGO — Mifepristone treatment improved glycemic control and led to weight loss and a reduction of waist circumference in patients with poorly controlled type 2 diabetes (T2D) and hypercortisolism, according to new data from the CATALYST trial.
Results from the prevalence phase of the study, presented last year, indicated that 24% (253) of the 1055 patients enrolled had hypercortisolism, as determined by dexamethasone suppression test. The figure was surprising, as the expected prevalence was 8%.
The current data were presented at the American Diabetes Association (ADA) 85th Scientific Sessions and simultaneously published in Diabetes Care .
'These findings demonstrate a potentially promising treatment solution' for these patients, who are often frustrated with their diabetes care, said study author John Buse, MD, PhD, Verne S. Caviness Distinguished Professor of Medicine at the University of North Carolina School of Medicine, Chapel Hill, North Carolina, in a press release.
The CATALYST Trial: Latest Results
In the second phase of CATALYST, individuals who had abnormal cortisol suppression were offered the opportunity to take part in a randomized trial of mifepristone, a medication that reduces the effects of cortisol. It is currently FDA approved for the treatment of elevated blood glucose in patients with hypercortisolism and prediabetes or T2D.
The trial took place at 36 sites in the US. A total of 136 patients with T2D (A1c of 7.5%-11.5%, who were on multiple medications) and hypercortisolism were randomized 2:1 to mifepristone (300-900 mg once daily; 91 patients) or placebo (45 patients) for 24 weeks, with stratification by presence/absence of an adrenal imaging abnormality.
Almost 40% of the patients were women, and the mean age was 63 years. The mean A1c was 8.55%, and mean BMI was 33.3. Twenty-eight percent of participants had adrenal imaging abnormalities.
The medication reduced A1c by 1.5% (95% CI, -1.79 to -1.14). For those taking placebo, A1c declined 0.2% from 8.41% to 8.36% (95% CI, -0.56 to 0.27).
Within the first 12 weeks, 30% of those taking mifepristone reduced or discontinued
fast-acting insulin compared to 11% of those taking placebo. And half reduced or discontinued long-acting insulin compared to 13% of those taking placebo.
'As their A1c came down, they didn't need the insulin,' Buse told reporters at a press conference at the meeting.
Patients taking mifepristone also lost 4.4 kg of body weight and had a 5.2 cm (2.05 in) reduction in waist circumference from baseline. However, almost 50% of those taking mifepristone discontinued due to adverse events compared to just 18% of those taking placebo.
A total of 62% of patients on mifepristone reported having treatment-related adverse events, said Buse, adding that people on mifepristone primarily experience glucocorticoid withdrawal syndrome or hypokalemia.
Mifepristone 'is a challenging drug to use,' he said, and 'it's important to set expectations appropriately with patients about steroid withdrawal symptoms and how to manage them.'
CATALYST already demonstrated that hypercortisolism was likely a culprit in almost a quarter of patients with poorly controlled diabetes, and screening with a dexamethasone suppression test is relatively easy, said Buse.
The treatment phase of CATALYST showed 'that identifying and addressing hypercortisolism is a novel path to improving diabetes care in millions of people worldwide,' he added.
The CATALYST investigators 'believe that there's sufficient evidence now to suggest guideline changes at the American Diabetes Association and other international health organizations.'
This study was funded by Corcept Therapeutics. Buse disclosed serving on an advisory panel/as a consultant for Altimmune, Antag Therapeutics, Amgen, APstem Therapeutics, Aqua Medical, AstraZeneca, Boehringer Ingelheim, CeQur, Corcept Therapeutics, Dexcom, Eli Lilly, embecta, GentiBio, Glyscend, Insulet, Medtronic MiniMed, Mellitus Health, Metsera, Novo Nordisk, Pendulum Therapeutics, Praetego, Stability Health, Tandem Diabetes Care, Terns Pharmaceuticals, Vertex Pharmaceuticals, and Zealand Pharma; and having stocks/shares in Glyscend, Mellitus Health, Metsera, Pendulum Therapeutics, Praetego, and Stability Health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
37 minutes ago
- CBS News
Northwestern University performing cost-cutting measures taking effect next year
Northwestern University is changing its tuition benefits program and health insurance for its staff and faculty beginning next year. According to the university, the changes are due to rising costs and other factors straining the school's finances. In an email earlier this month, the university informed staff and faculty that on Jan. 1, 2026, it will change from Blue Cross Blue Shield to UnitedHealthcare and new dental and prescription insurance providers. The move is forcing staff to petition the board of trustees to allow them to keep the Blue Cross. The university said that without the changes, employees would pay more, and the school would be forced to make additional cuts in other areas beyond what they've already announced. Changes to the tuition benefits program, which allows staff to take courses at a discount, will also be made for new and returning hires. Current faculty and staff will not be affected by the changes. Now, the school will cap the program at $12,000 per year.
Health Line
41 minutes ago
- Health Line
When Is the Best Time to Take Vitamins?
You can take most vitamins at any time of the day. But your body may absorb some nutrients better if you take them with a meal containing fat. To function properly, your body needs 13 vitamins — 9 of which are water-soluble and 4 of which are fat-soluble. While these nutrients are found in varying amounts in food, some people need to supplement with certain vitamins to meet their nutritional requirements. Normally, most vitamins can be taken at any time of day. That said, some vitamins are better absorbed under special conditions, which is why it's good to know how and when to take a supplement to promote optimal absorption. This article explains how and when to take vitamins. Water-soluble vitamins As the name implies, water-soluble vitamins dissolve in water. As such, you don't need to take them with food for them to be absorbed. There are nine water-soluble vitamins, which include vitamin C plus the eight B vitamins — B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folate), and B12 (cobalamin). You need to regularly consume water-soluble vitamins because, unlike fat-soluble vitamins, they're not readily stored in your body's tissues. Instead, excess water-soluble vitamins are excreted through your urine. Vitamin C Vitamin C plays many critical roles in your body. For example, it functions as a powerful antioxidant and is needed for immune health, as well as collagen and neurotransmitter synthesis. There are several forms of vitamin C supplements, including ascorbic acid, ascorbic acid with bioflavonoids, liposomal vitamin C, and calcium ascorbate. Ascorbic acid supplements have a bioavailability similar to that of the ascorbic acid found in foods like fruits and vegetables. You can take vitamin C supplements at any time of day, with or without food, although taking ascorbic acid with foods can help decrease the potential gastrointestinal side effects caused by its high acidity. Make sure to store vitamin C supplements in a cool, dark place, as this nutrient is sensitive to heat and light. B vitamins B vitamins are sold individually or as B complex supplements that contain all eight B vitamins. Because they're water-soluble, you can take them with or without food and at any time of the day. That said, it's often recommended to take B vitamins in the morning due to their important role in nutrient metabolism and energy production. What's more, some people may benefit from taking B vitamins on an empty stomach. For example, it's recommended that people with a B12 deficiency take B12 supplements on an empty stomach with water to promote maximal absorption. Fat-soluble vitamins Unlike water-soluble vitamins, fat-soluble vitamins depend on fat for proper absorption. Thus, it's generally recommended that you take fat-soluble compounds with a meal that contains fat. Vitamin A Vitamin A deficiency is rare in the United States but more common in developing countries. Certain populations are more at risk of developing vitamin A deficiency due to increased needs or reduced absorption. This includes people who are pregnant and nursing and those with cystic fibrosis. Most vitamin A supplements contain vitamin A derived from fish liver oil or in the form of vitamin A carotenoids, which are plant compounds that your body converts into the active form of vitamin A. To promote optimal absorption, you should take vitamin A supplements with a fat-containing meal. Keep in mind that if you eat a balanced diet, taking vitamin A supplements typically isn't necessary. Plus, some evidence suggests that high dose vitamin A supplements may increase the risk of all-cause and cancer-related mortality. For this reason, don't supplement with high dose vitamin A unless a healthcare professional recommends doing so. Vitamin D Vitamin D is needed for immune function, bone health, cellular growth, and more. More than 1 billion people worldwide are deficient in this important nutrient. Vitamin D can be taken at any time of day, and most of these supplements should be taken with fat-containing meals or snacks to ensure optimal absorption. For example, one study in 50 older adults found that vitamin D absorption was 32% greater in those who took a vitamin D supplement with a fat-containing meal compared with those who took it with a fat-free meal. However, some vitamin D supplements aren't affected by what you eat. For example, one animal study found that oil-based and microsomal vitamin D supplements — vitamin D encapsulated in fatty acid spheres — can be taken without food. It's important to note that vitamin D activation depends on having adequate levels of magnesium. Therefore, to maintain healthy vitamin D levels, make sure you're also getting enough magnesium. Also, keep in mind that certain fat-soluble vitamins, including vitamin E, may affect vitamin D absorption. On the other hand, taking vitamin K alongside vitamin D may benefit bone mineral density. Vitamin E Vitamin E functions as a major antioxidant in your body and is essential for healthy blood flow and immune function. It's also a popular dietary supplement — even though this nutrient is found in many foods and deficiency is rare. That said, people who have certain medical conditions, including short bowel syndrome, cystic fibrosis, and Crohn's disease, may have to supplement with vitamin E to avoid deficiency. It's typically recommended that vitamin E supplements are taken with a meal. However, one 2019 study in 27 women found that as long as fat was ingested throughout the day, vitamin E was absorbed effectively. This means it may not be necessary to take vitamin E with a fat-containing meal as long as you consume enough fat at subsequent meals. Keep in mind that even though vitamin E is essential to health, taking too much in supplement form could cause harm in certain populations. For instance, some older research suggests that high dose vitamin E supplements may lead to an elevated risk of prostate cancer in healthy men. Vitamin K Vitamin K refers to a family of fat-soluble compounds that includes vitamin K1 (phylloquinone) and vitamin K2 (menaquinones). Vitamin K is needed for blood clotting, bone and heart health, and more. Clinically significant vitamin K deficiency is rare in adults, although it's more common in those with bleeding disorders and malabsorption conditions, as well as in people taking medications that interfere with vitamin K absorption. You can take vitamin K supplements at any time of day with a meal or snack that contains fat. Because most people get enough vitamin K through their diet, it's not recommended to take high dose supplements unless a healthcare professional recommends doing so — even though these supplements are generally safe and not related to significant side effects. Nevertheless, vitamin K supplements may interfere with certain anticoagulant medications. If you're taking these medications, consult your healthcare professional before taking vitamin K. If possible, take vitamin K separately from the fat-soluble vitamins E and A. On the other hand, taking vitamins D and K together can be beneficial, as these nutrients work synergistically to promote bone health and healthy calcium levels in your body. Multivitamins Multivitamins typically contain a variety of vitamins and minerals. Some people prefer multivitamins over single-nutrient supplements because they're convenient and can be less expensive. Although data on the long-term health benefits of taking a multivitamin is inconsistent, it's known that taking them can help fill nutrient gaps, particularly in vulnerable populations like older adults and people who are pregnant. Because these supplements commonly contain both fat- and water-soluble vitamins, it's typically recommended to consume them with a meal. This may enhance the absorption of certain nutrients while reducing the risk of gastrointestinal upset, which can otherwise occur when taking a multivitamin on an empty stomach. If you're taking two or more pills per day, consider splitting the dose to help your body absorb certain nutrients more effectively. For example, take one pill with breakfast and one with lunch. If you have questions about dosing or how to take your vitamin supplements, consult your healthcare professional for advice. The bottom line Your body absorbs and stores nutrients in different ways. This should be considered when taking single-nutrient supplements and multivitamins. For example, some nutrients are better absorbed with meals, while others can be taken on an empty stomach.
CNN
44 minutes ago
- CNN
What to know about thimerosal, a target of RFK Jr.'s new CDC vaccine advisers
Vaccines Disability issues Federal agencies Children's healthFacebookTweetLink Follow A century ago, one of the biggest safety concerns about vaccines involved bacterial contamination. In 1916, four young children died in South Carolina after receiving typhoid vaccine that had been contaminated with Staphylococcus aureus bacteria. Twelve years later, 12 children in Queensland, Australia, died from tainted immunizations against diphtheria. In the 1930s, vaccine makers began using a preservative called thimerosal to stave off microbial growth in their products. For the next six decades, it didn't receive much notice; ill effects appeared limited to minor local injection-site reactions, according to the US Food and Drug Administration. That changed in 1999, when US health officials asked pharmaceutical companies to remove thimerosal from vaccines. There was no evidence that it caused harm in the quantities used, but thimerosal contains a form of mercury, and questions had emerged about whether it could cause neurotoxicity when given in childhood vaccinations. Vaccine makers have removed it from all but a few shots, such as multidose vials of flu vaccine. In the meantime, subsequent studies have confirmed no link between thimerosal in vaccines and neurodevelopmental issues, including autism, and autism rates have continued to rise. So public health experts were puzzled when the preservative appeared on the agenda for this week's meeting of outside vaccine advisers to the US Centers for Disease Control and Prevention. 'I actually don't know any pediatric practices that even use that multidose influenza vaccine,' said Dr. Sean O'Leary, a pediatrician at Children's Hospital Colorado and former liaison to the CDC's Advisory Committee on Immunization Practices, or ACIP, for the American Academy of Pediatrics. The group is meeting on Wednesday and Thursday for the first time since US Health and Human Services Secretary Robert F. Kennedy Jr. dismissed the committee's previous 17 members, claiming they had conflicts of interest, and days later installed eight new advisers. Public health experts and lawmakers have called into question the credentials and backgrounds of some of the new panelists, and just before the meeting began, one member withdrew during the financial holdings review, an HHS spokesman said, bringing the panel down to seven. A presentation 'regarding thimerosal in vaccines' is scheduled for Thursday morning, followed by 'proposed recommendations' specifically about thimerosal in flu vaccines, according to an agenda posted Monday. The meeting is scheduled to conclude with a vote on the latter, a move that could lead to official CDC policy if adopted by agency leadership – or, without a confirmed director in place, by Kennedy. The last-minute addition of thimerosal to the agenda was a red flag for vaccine experts, who consider the science settled and fear that Kennedy – who led an anti-vaccine group called Children's Health Defense – is seeking to sow doubt about vaccine safety. Another former Children's Health Defense leader, Lyn Redwood, is slated to make a presentation on the topic at the meeting. Here's how thimerosal became such a hot-button issue. In 1997, Rep. Frank Pallone, a New Jersey Democrat concerned about mercury pollution in his community's lakes and rivers, attached an amendment to a US Food and Drug Administration reauthorization bill that would require the agency to catalogue intentionally introduced mercury compounds in drugs and food. That led to a possibly startling discovery: 'As people looked in vaccines, there was the potential that, by six months of age, infants could have received more thimerosal than was listed in several sources of what was considered safe levels of mercury,' said Dr. Walter Orenstein, who was director of the National Immunization Program at the CDC at the time. But those limits were set for methylmercury, the kind found in some fish, which is known to be toxic. Thimerosal contains ethylmercury, a different compound that's 'intrinsically less stable, and more readily metabolized, than methylmercury,' said Dr. Matthew Rand, an associate professor in the Department of Environmental Medicine at the University of Rochester who studies mercury toxicity. That means it's cleared from the body more quickly than methylmercury, according to the CDC, 'and is therefore less likely to cause any harm.' The FDA notes that there were no existing guidelines for ethylmercury. Still, the finding led to a number of emergency meetings among federal health officials and outside groups to determine what should be done, Orenstein recalled. 'While there was no evidence of harm from thimerosal, the general feeling was, 'let's get rid of it, because we don't need it,' ' he said. Moving to single-dose containers alleviated the need for a preservative, although it came at a higher expense for manufacturers. In 1999, the FDA sent a letter to manufacturers of US vaccines requesting their plans to remove thimerosal, and by 2001, the compound had been removed from or reduced in all vaccines routinely recommended for children under 6 in the US, according to the CDC. The message from public health agencies, Orenstein said, was 'we're going to make safe vaccines even safer.' But the die was cast. Vaccines had already been tied to autism in 1998 by British doctor Andrew Wakefield, who published a since-retracted paper that claimed the measles-mumps-rubella vaccine was linked to autism, although not because of thimerosal – the MMR vaccine never contained the preservative. Still, parents of children with autism were seeking answers. One of those parents was Redwood, who said that in 1999, she tallied up her son's mercury exposure and found 'at two months of age, he had received 125 times his allowable exposure to mercury based on EPA's guidelines in his weight.' 'That was a real answer for me,' Redwood said in a video posted by Children's Health Defense this month, 'because my son at this time was almost 5 years old, and he had regressed developmentally after his first year of life and was diagnosed with autism.' Redwood, a nurse practioner, decided to become an advocate, speaking at events and publishing papers about thimerosal and autism. The uproar over a potential link between thimerosal and autism came as a surprise to Orenstein and colleagues. 'Mercury itself had never been implicated as a major cause of autism,' Orenstein said. 'But this was a major, major concern.' It led to a number of studies of the issue, including a 2004 assessment by the Institute of Medicine (now known as the National Academy of Medicine) that concluded 'the body of epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines and autism.' It made the same conclusion for MMR vaccines and autism. A 2010 study by the CDC also found no link. And 'even after thimerosal was removed from almost all childhood vaccines, autism rates continued to increase,' the agency noted, 'which is the opposite of what would be expected if thimerosal caused autism.' Still, those who continued to push the disproven autism connection included Kennedy, who published a book in 2014 called 'Thimerosal: Let the Science Speak.' Its subtitle calls for the 'immediate removal of mercury – a known neurotoxin – from vaccines.' It rejects the findings of the 2004 Institute of Medicine report and warns that millions of children in the US and around the world 'appear to be at risk of injury from the thimerosal in vaccines.' Thimerosal is still present in 'a small percentage of flu vaccines, confined to multidose vials,' according to a post from the Vaccine Integrity Project, a group focused on countering vaccine misinformation that was started at the University of Minnesota's Center for Infectious Disease Research and Policy, or CIDRAP. The group suspects that thimerosal is included on ACIP's agenda this week – with a presentation by Redwood and a vote by the committee – 'to put greater focus on and generate more public discussion about vaccine risk.' HHS didn't return a request for comment about Redwood's involvement in this week's meeting, and Redwood declined to comment. Her presentation slides, however, were posted ahead of the meeting and continued to claim thimerosal presents safety risks. One slide initially included in the presentation cited a study in animals that appeared not to exist; its apparent lead author told CNN he'd published a study with a similar title, but in a different journal, in different animals, and with dramatically different findings — ones that didn't appear to show a link between autism and thimerosal. The slide presentation was subsequently updated to remove that slide. CDC staff also posted its own review of the data, citing nearly two dozen studies showing 'the evidence does not support an association between thimerosal-containing vaccines and autism spectrum disorder or other neurodevelopmental disorders.' During her Senate Health, Education, Labor and Pensions committee confirmation hearing on Wednesday, Dr. Susan Monarez, President Donald Trump's pick to lead the CDC, said, 'I have not seen a causal link between vaccines and autism.' The decision to remove thimerosal from most vaccines, despite no evidence of harm, had other consequences. At the same time the FDA made its request to vaccine makers, US health authorities advised that babies born to mothers known to be negative for hepatitis B not receive a shot for that virus at birth, but at two months to 6 months of age, as thimerosal was phased out. But about 10% of hospitals 'suspended use of the hepatitis B vaccine for all newborns, regardless of their level of risk,' wrote Dr. Paul Offit, a vaccine scientist at the Children's Hospital of Philadelphia and a member of the FDA's outside advisory committee on vaccines, in a 2007 perspective piece in the New England Journal of Medicine. 'One three-month-old child born to a Michigan mother infected with hepatitis B virus died of overwhelming infection.' Orenstein looks back on the decision to remove thimerosal as a hard one. 'The fear would be keeping it in there, doing a study over two or three years and then it showed harm, and lo and behold, for three years, we used this vaccine and this component was harmful,' he said. 'Since we didn't know what the results would be of any of the studies at the time, we thought it better to just get it out of there. 'The autism issue,' he added, 'didn't play any role in the initial decision.' CNN's Brenda Goodman contributed to this report.
